A Pilot Study to Define PROs for Establishing a Pathway for Post Radiation or Concurrent Chemo Radiation (RT/CRT) Patient Care for Oropharyngeal Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Oropharyngeal Carcinoma
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 77
- Locations
- 1
- Primary Endpoint
- Scores of symptoms on the MD Anderson Symptom Inventory - Head and Neck (MDASI-HN) relevant to toxicities
- Status
- Active, not recruiting
- Last Updated
- 3 months ago
Overview
Brief Summary
This study examines patient reported outcomes post radiation therapy or chemoradiotherapy patient care in patients with oropharyngeal cancer. This study may help researchers learn about the symptoms that patients with oropharyngeal cancer have after completing radiation therapy.
Detailed Description
PRIMARY OBJECTIVE: I. To provide evidence of clinically relevant symptoms for integrating into a user-friendly, automated pathway for real-time tracking and management of symptoms during post radiation therapy (RT)/chemoradiation (CRT) for oropharyngeal cancer (OPC). OUTLINE: Patients complete questionnaire over 10-20 minutes at baseline, 2 times every week during weeks 1-8 of radiation therapy, and at the end of the study.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who were seen for new patient evaluation at clinics and HNC centers at MD Anderson Cancer Center
- •Adult patients with OPC (\> 18 years old) who have been enrolled under PA14-0947
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Scores of symptoms on the MD Anderson Symptom Inventory - Head and Neck (MDASI-HN) relevant to toxicities
Time Frame: From the end of radiation therapy (RT)/chemoradiotherapy (CRT) treatment to 2 months post-treatment
All symptom PRO items on MDASI-HN (MD Anderson Symptom Inventory - Head and Neck (MDASI) would be rated by patients on 0 -10 of severity scale, with 0 being no symptom, and 10 being symptom as bas as imagine.